U.S. flag

An official website of the United States government

NM_001033.5(RRM1):c.1142G>A (p.Arg381His) AND Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 6

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 7, 2023
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003447337.2

Allele description [Variation Report for NM_001033.5(RRM1):c.1142G>A (p.Arg381His)]

NM_001033.5(RRM1):c.1142G>A (p.Arg381His)

Gene:
RRM1:ribonucleotide reductase catalytic subunit M1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.4
Genomic location:
Preferred name:
NM_001033.5(RRM1):c.1142G>A (p.Arg381His)
HGVS:
  • NC_000011.10:g.4123206G>A
  • NG_027992.2:g.33513G>A
  • NM_001033.5:c.1142G>AMANE SELECT
  • NM_001318064.1:c.851G>A
  • NM_001318065.1:c.128G>A
  • NM_001330193.1:c.476G>A
  • NP_001024.1:p.Arg381His
  • NP_001304993.1:p.Arg284His
  • NP_001304994.1:p.Arg43His
  • NP_001317122.1:p.Arg159His
  • LRG_324t1:c.1142G>A
  • LRG_324:g.33513G>A
  • LRG_324p1:p.Arg381His
  • NC_000011.9:g.4144436G>A
Protein change:
R159H; ARG381HIS
Links:
OMIM: 180410.0001
Molecular consequence:
  • NM_001033.5:c.1142G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001318064.1:c.851G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001318065.1:c.128G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001330193.1:c.476G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 6
Identifiers:
MONDO: MONDO:0957993; MedGen: C5882731; OMIM: 620647

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004174823OMIM
no assertion criteria provided
Pathogenic
(Dec 7, 2023)
germlineliterature only

Shintaku, J., Pernice, W. M., Eyaid, W., Gc, J. B., Brown, Z. P., Juanola-Falgarona, M., Torres-Torronteras, J., Sommerville, E. W., Hellebrekers, D. M., Blakely, E. L., Donaldson, A., van de Laar, I., and 12 others RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis. J. Clin. Invest. 132: e145660, 2022.

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Details of each submission

From OMIM, SCV004174823.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature onlynot provided

Description

In 2 patients (patients 1a and 1b) from a consanguineous Saudi Arabian family with autosomal recessive progressive external ophthalmoplegia-6 (PEOB6; 620647), Shintaku et al. (2022) identified homozygosity for a c.1142G-A transition (c.1142G-A, NM_001033.5) in the RRM1 gene, resulting in an arg381-to-his (R381H) substitution. The mutation, which was identified by whole-exome sequencing, segregated with disease in the family. The mutation was not present in the gnomAD database (v2.1.1). Ribonucleotide reductase activity was reduced in fibroblasts from the patients, and mtDNA was reduced in proliferating fibroblasts from the patients.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 23, 2024